Unintended pregnancy in a commercially insured population.

被引:14
|
作者
Green D.C. [1 ]
Gazmararian J.A. [1 ]
Mahoney L.D. [1 ]
Davis N.A. [1 ]
机构
[1] Department of Health Policy and Management, Emory Center on Health Outcomes and Quality, Rollins School of Public Health of Emory University, Atlanta, 30322, Georgia
关键词
pregnancy; unwanted pregnancy; contraception behavior; health services research; managed care programs;
D O I
10.1023/A:1019778129435
中图分类号
学科分类号
摘要
OBJECTIVES: While much attention has been focused on unintended pregnancy in disadvantaged populations, few studies have focused on women in lower risk groups. This study, conducted in a national managed care organization, reports the prevalence of unintended pregnancy resulting in live births and examines associated factors METHODS: Women ages 18-49 who delivered a live infant during a 6-month interval were eligible for the study. Telephone surveys were conducted after delivery. We report the rate of unintended pregnancy resulting in a live birth, and describe its association with sociodemographic and pregnancy-related factors, partner's intention status, and contraceptive use. RESULTS: Of 1173 births, 29% were unintended. Women who reported that the partner did not want the pregnancy were 7.4 times more likely than women whose partner wanted the pregnancy to regard the pregnancy as unintended. Only 40% of the women with an unintended birth used birth control and 64% of those used less effective methods such as condoms and diaphragms. CONCLUSIONS: In a population where the majority of women were married, educated, and with incomes over $40,000, almost 1/3 of the births resulted from unintended pregnancies. Future research is needed to help us better understand contradictions in pregnancy intention and contraceptive behavior. Comprehensive efforts are needed to promote consistent and correct use of contraception by women at risk for unintended pregnancy, and to involve male partners in family planning.
引用
收藏
页码:181 / 187
页数:6
相关论文
共 50 条
  • [11] Care Among Migraine Patients in a Commercially Insured Population
    Bonafede, Machaon
    McMorrow, Donna
    Noxon, Virginia
    Desai, Pooja
    Sapra, Sandhya
    Silberstein, Stephen
    [J]. NEUROLOGY AND THERAPY, 2020, 9 (01) : 93 - 103
  • [12] Patterns of radiograph use in a population of commercially insured children
    Fontana, Margherita
    Yepes, Juan F.
    Eckert, George J.
    Hale, Kevin J.
    Benavides, Erika
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2022, 153 (05): : 405 - 413
  • [13] Resource Utilization and Cost in a Commercially Insured Population with Schizophrenia
    Fitch, Kathryn
    Iwasaki, Kosuke
    Villa, Kathleen F.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (01): : 18 - 25
  • [14] Cost of dental services in private practice for an insured population.
    Sivaneswaran, S
    Lazarus, R
    Barnard, PD
    [J]. JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 947 - 947
  • [15] Effect of race and age on mammography utilization in an insured population.
    Harris, RB
    Delate, T
    Harris, JM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s64 - s64
  • [16] UNDERSTANDING OPIOID OVERDOSE RISK IN A COMMERCIALLY INSURED POPULATION
    Halim, L.
    Shah, J.
    Bretzke, D.
    Needs, P.
    Couto, J.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A292 - A292
  • [17] Epidemiology of AL Amyloidosis in a US Commercially Insured Population
    Quock, Tiffany P.
    Yan, Jessie T.
    Chang, Eunice
    Guthrie, Spencer D.
    Broder, Michael S.
    [J]. BLOOD, 2017, 130
  • [18] The impact of rheumatoid arthritis on the commercially insured population in the US
    Kessler, R.
    Petukhova, M.
    Maclean, R.
    Li, T.
    Stang, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 266 - 266
  • [19] Validation of TTP Diagnostic Codes in a Commercially Insured Population
    Wahl, Peter M.
    Rodgers, Keith
    George, James N.
    Terrel, Deirdra R.
    Uhl, Lynne
    Cataland, Spero
    Bohn, Rhonda L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S159 - S159
  • [20] Costs of treating Paget's disease in a privately insured population.
    Briesacher, B
    Orwig, D
    Seton, M
    Omar, M
    Kristijan, K
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S179 - S179